A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Amyotrophic Lateral Sclerosis

Study Purpose:

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding ALS

Study Status:

Recruiting

Disease:

ALS , Amyotrophic Lateral Sclerosis , Motor Neuron Disease

Study Type:

Observational

Type of Intervention:

N/A

Intervention Name:

N/A

Placebo:

N/A

Phase:

N/A

Study Chair(s)/Principal Investigator(s):

Sabine Hazan, MD, ProgenaBiome

Clinicaltrials.gov ID:

NCT04150809

Neals Affiliated?

No

Coordinating Center Contact Information

ProgenaBiome

Sabine Hazan, MD / email hidden; JavaScript is required / 18053390549

Ventura, California, 93003 United States

Full Study Summary:

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding ALS

Study Sponsor:

ProgenaBiome

Estimated Enrollment:

100

Estimated Study Start Date:

03 / 02 / 2020

Estimated Study Completion Date:

07 / 01 / 2023

Posting Last Modified Date:

09 / 05 / 2021

Date Study Added to neals.org:

11 / 05 / 2019

Minimum Age:

N/A

Maximum Age:

N/A

Can participants use Riluzole?

Yes

Inclusion Criteria:

1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study

2. Male or female patients of any age (interest is given to children to compare with mothers).

3. Diagnosis of ALS

Exclusion Criteria:

1. Refusal to sign informed consent form

2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.

3. Postoperative stoma, ostomy, or ileoanal pouch

4. Participation in any experimental drug protocol within the past 12 weeks

5. Treatment with total parenteral nutrition

6. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial

7. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

ProgenaBiome | Recruiting

Sabine Hazan, MD / 805-339-0549 / email hidden; JavaScript is required

Jordan Daniels, MS / 18053390549 / email hidden; JavaScript is required

Principal Investigator : Sabine Hazan, MD

Ventura, California 93003
United States